Business Wire

Nominations Open for Fourth Annual Digital Engineering Awards Presented by L&T Technology Services, ISG & CNBC-TV18

24.9.2025 10:30:00 CEST | Business Wire | Press Release

Share

L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced the launch of the fourth annual Digital Engineering Awards presented in partnership with Information Services Group (ISG), a global AI-centered technology research and advisory firm, and CNBC-TV18, India’s premier business news channel.

The Digital Engineering Awards have earned their place as the most distinguished global recognition of excellence in the field of digital engineering. The winners of this fourth annual awards will be announced on March 12, 2026, during a gala event in Boston, Massachusetts. Finalists will also have an exclusive opportunity to visit the world-renowned MIT Media Lab for an in-depth glimpse into innovations shaping the future.

Nominations are open from September 23, 2025, through December 20, 2025. Enterprises and service providers worldwide are invited to submit their entriesHERE.

This year, recognizing the growing significance of AI across industries, the Digital Engineering Awards have introduced a new AI-focused category under the Engineering The Change segment – the Physical AI Impact of the Year Award. This is in addition to two other AI-focused categories - AI Impact of the Year (Engineering The Change) & AI Trailblazer of the Year (Engineer At Heart). These additions underscore the program’s commitment to honoring excellence in the rapidly evolving AI space.

The Digital Engineering Awards offer a global platform to celebrate visionaries driving innovation at the intersection of AI, technology, sustainability, and transformation. Over the past three years, the Awards have celebrated leaders from renowned organizations, including Airbus, GE Healthcare, Qualcomm Technologies, Intel Corporation, Philips, BMW Group, Eaton, AT&T, Chevron, T-Mobile, and others. To view the detailed list of winners from the past three editions, click here: 2024, 2023, 2022.

A distinguished global jury, including expert representatives from ISG, will evaluate submissions across 12 categories under the following key segments:

  • Engineering The Change (Team Awards)
    Recognizing excellence in initiatives such as Digital Transformation of the Year, Digital Engineering Project/Program of the Year, Engineering Product of the Year, AI Impact of the Year, Top Sustainability Initiative, Excellence in Value Realization, and the newly introduced Physical AI Impact of the Year.
  • Engineer At Heart (Individual Awards)
    Honoring changemakers, including The Distinguished Digital Engineering Leader, The Digital Engineer of the Year, The Woman Engineer of the Year, The Innovator of the Year, AI Trailblazer of the Year.

The awards spotlight individuals and organizations that are redefining industries, paving the way for sustainable growth and shaping a smarter, more innovative future through groundbreaking digital advancements.

Submit your nominations now at https://www.digitalengineeringawards.com/.

About the Digital Engineering Awards

The Digital Engineering Awards bring together industry leaders to recognize outstanding achievements in the R&D domain, and to help global organizations give shape to their transformative ideas. The Awards are produced by L&T Technology Services in association with ISG, with CNBC-TV18 as a media partner.

To learn more about the Awards, visit our website or contact us.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.

About Network18

Network18 Media & Investments Limited (Network18 Group) is one of India’s most diversified media and entertainment (M&E) conglomerates, with a presence across television, digital, and print platforms. Its portfolio includes 20 TV channels in 16 languages and 4 online news platforms in 13 languages. It operates India’s widest-reaching TV news network, engaging over 180 million viewers weekly and holding a viewership share of 14.1%. Network18’s digital portfolio is India’s No. 1 digital news and information publisher, with an extensive network that spans national, international, business, general, and regional news. Marquee brands such as CNBC-TV18, News18 India, and CNN-News18 are part of this news bouquet. For more information, visit: https://www.nw18.com/corporate.

About L&T Technology Services Ltd

L&T Technology Services (LTTS) is a global leader in AI, Digital & ER&D Consulting Services. A listed subsidiary of Larsen & Toubro (L&T), we offer design, development, testing, and sustenance services across products and processes.

Purposeful. Agile. Innovation. is how we drive growth across the Mobility, Sustainability and Tech segments. Our customer base includes 69 Fortune 500 companies and 57 top ER&D companies across industrial products, medical devices, transportation, telecom & hi-tech, and process industries. Headquartered in India, we have over 23,600 employees across 23 global design centers, 30 global sales offices, and 105 innovation labs, as of June 30, 2025. For more information, please visit www.LTTS.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250923060631/en/

Contacts

Media Contact Details
Aniruddha Basu, L&T Technology Services Limited, Aniruddha.Basu@LTTS.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye